The Indian Journal of Chest Diseases and Allied Sciences

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  66 (2024)
Volume  65 (2023)
Volume  64 (2022)
Volume  63 (2021)
Volume  62 (2020)
Volume  61 (2019)
Volume  60 (2018)
Volume  59 (2017)
Volume  58 (2016)
Volume  57 (2015)
Volume  56 (2014)
Volume  55 (2013)
Volume  54 (2012)
Volume  53 (2011)
Volume  52 (2010)
Related articles

VOLUME 61 , ISSUE 2 ( April-June, 2019 ) > List of Articles

Original Article

To Study Association Between Exhaled Carbon Monoxide Levels with Disease Severity in Various Stages of Obstructive Airway Disease

Mohammad Shameem, Arshad Ejazi, Shahnawaz Mohd, Nabeela Khanam

Keywords : Obstructive airway disease, Exhaled carbon monoxide, FEV1, Smoking

Citation Information : Shameem M, Ejazi A, Mohd S, Khanam N. To Study Association Between Exhaled Carbon Monoxide Levels with Disease Severity in Various Stages of Obstructive Airway Disease. Indian J Chest Dis Allied Sci 2019; 61 (2):83-86.

DOI: 10.5005/ijcdas-61-2-83

License: NA

Published Online: 18-06-2019

Copyright Statement:  NA


Abstract

Background: Chronic obstructive pulmonary disease (COPD) is a general name for the chronic airflow obstruction that develops most commonly due to long term tobacco smoking and other noxious gases. The aim of the present study is to check whether exhaled carbon monoxide (CO) levels had any co-relations with disease severity in various stages of COPD. Methods: The clinical severity of asthma and COPD was determined using the criteria defined in the Global Initiative for Asthma (GINA) and Global Initiative for chronic obstructive pulmonary disease (GOLD) guidelines. Spirometry was used to confirm the presence of airway obstruction. Results: We observed that exhaled CO levels increased with increasing severity of airway obstruction. A statistically significant negative correlation was observed between forced expiratory volume in the first second and exhaled CO (p<0.05). Conclusions: We found that measuring the level of exhaled CO in patients with COPD along with spirometry forms a new approach for better understanding of the pathophysiology of COPD cases.

PDF Share
  1. Rutgers SR, Postam DS, ten Hacken NH, Kaufmann HF, Van der Mark TW, Koeter GH, et al. Ongoing airway inflammation in patients with COPD who do not currently smoke. Thorax 2000;55:12–8.
  2. Murray CJL, Lopez AD. Evidence-based health policy—lessons from the Global Burden of Disease Study. Science 1996;274:740–3.
  3. Postma DS, Boezen HM. The natural history of chronic obstructive pulmonary disease. Eur Respir Mon 2006;38:71–83.
  4. Pouwels RA, Buist AS, Ma P. GOLD scientific committee Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. Executive summary. Am J Respir Crit Care Med 2001;46:798–825.
  5. Buist S. COPD: a common disease that is preventable and treatable. Prim Car Resp J 2006;15:7–9.
  6. Gasselink R, Troosters T, Decramer M. Peripheral muscle weakness contributes to exercise limitation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996;153:976–80.
  7. Carter R, Peavler M, Zinkgraf S, Williams J, Fields S. Predicting maximal exercise ventilation in patients with chronic obstructive pulmonary disease. Chest 1987;92:253–9.
  8. Jenkins C, Rodríguez-Roisin R. Quality of life, stage severity and COPD. Eur Respir J 2009;33:953–5.
  9. Koistinen K, Kotzias D, Kephalopoulos S, Schlitt C, Carrer P, Jzntunen, et al. The INDEX project: executive summary of a European Union project on indoor air pollutants. Allergy 2008;63:810–9.
  10. Harrison RM, Thornton CA, Lawrence RG, Mark D, Kinnersely RP, Ayres JG. Personal exposure monitoring of particulate matter, nitrogen dioxide and carbon monoxide, including susceptible groups. Occup Environ Med 2002;59:671–9.
  11. Scherer G. Carboxyhemoglobin and thiocyanate as biomarker of exposure to carbon monoxide and hydrogen cyanide in tobacco smoke. Exp Toxicol Pathol 2006;58:101–24.
  12. Salameh P, Aoun Bacha Z, Waked M. Saliva cotinine and exhaled carbon monoxide in real life waterpipe smokers: a post-hoc analysis. Tob Use Insights 2009;2:1–10.
  13. Goniewich ML, Czogala J, Kosmider L, Koszowski B, Zielinska- Danch W, Sobczak A. Exposure to carbon monoxide from second hand tobacco smoke in Polish pubs. Cent Eur J Public Health 2009;17:220–2.
  14. Abdel Khalek K, el Kholey M, Rafik M, Ftahalla M, Heikal E. Effect of triiodothyroninr on cyclic AMP and pulmonary function tests in bronchial asthma. J Asthma 1991;28:425–31.
  15. Kharitonov SA, Barnes PJ. Exhaled marker of pulmonary disease. Am J Respir Crit Care Med 2001;163:1693–1722.
  16. Erhan Deveci, Yasemin Açik, A. Tevfik Ozan, Figen Deveci. The measurement of exhaled carbon monoxide in healthy smokers and non-smokers. Respir Med 2004;98:551–6.
  17. Sunyer J, Saez M, Murillo C, Castellsague J, Martinez F, Anto JM. Air pollution and emergency room admissions for chronic obstructive pulmonary disease: a 5 year study. Am J Epidemiol 1993;137:701–5.
  18. Yasuda H, Suzuki T, Zayasu K, Ishizuka S, Kubo H, Sasaki T, et al. Inflammatory and bronchospastic factors in asthma exacerbations caused by upper respiratory tract infections. Tohoku J Exp Med 2005;207:109–18.
  19. Montuschi P, Kharitonov Sa, Barrnes PJ. Exhaled carbon monoxide and nitric oxide in COPD. Chest 2001;20:496–501.
  20. Mahesh PA, Jayaraj BS Prahalad ST, Chaya SK. Validation of a structured questionare for COPD and prevalence of COPD: a pilot study. Lung India 2009;26:63–69.
  21. Tzanakis N, Anagnostopoulou U, Filaditaki V, Christaki P, Siafakas N. COPD group of the Hellenic Thoracic Society. Prevalence of COPD in Greece. Chest 2004;125:892–900.
  22. Middleton ET, Morice AH. Breathe carbon monoxide as an indication of smoking habit. Chest 2000;117:758–63.
  23. Kharitonov SA. Exhaled carbon monoxide and nitric oxide in asthma. Eur Respir J 1999;9:212–8.
  24. Yuvarajan Sivagnaname. Utility of measuring exhaled carbon monoxide (ECO) level in addition to pulmonary function test (spirometry) in the monitoring of chronic obstructive pulmonary disease (COPD). Int J Med Sci Public Health 2014;3:289–94.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.